Eggerthella

Eggerthella is a genus of Gram-positive, strictly anaerobic, non-spore-forming bacteria in the family Eggerthellaceae (phylum Actinobacteria). The most studied species, Eggerthella lenta, was originally classified as Eubacterium lentum before reclassification. It is a normal resident of the human colon at low abundance, but its metabolic versatility — particularly its ability to degrade drugs and hormones — makes it disproportionately influential.

What distinguishes Eggerthella from a WikiBiome perspective is its role at the intersection of drug metabolism, hormone recirculation, and metal-tolerant opportunism. It participates in an interspecies metabolic relay with enterococcus faecalis that degrades levodopa in the gut, directly affecting Parkinson's disease treatment. It also expands in metal-disturbed ecosystems where Clostridia are depleted, marking it as an indicator of heavy metal-driven dysbiosis.

Metal Dependencies

Eggerthella lenta relies on several metal cofactors for its diverse reductase enzymes:

  • Iron: Required for electron transport chains in anaerobic respiration. E. lenta uses iron-containing oxidoreductases for its dehydroxylation reactions.
  • Cobalt: The cardiac glycoside reductase (Cgr) operon that inactivates digoxin requires cobalamin (vitamin B12) as a cofactor, linking cobalt availability to drug metabolism.
  • Molybdenum: Molybdopterin-dependent enzymes participate in the reductive metabolism that defines the genus.

Unlike many strict anaerobes that are sensitive to heavy metals, Eggerthella appears to be metal-tolerant. In multiple sclerosis cohorts, E. lenta expands precisely when metal-sensitive Clostridia are depleted — a pattern consistent with cadmium, lead, and nickel exposure selectively removing competitors (miyake 2015 dysbiosis ms clostridia depletion, cross-sectional).

Key Enzymes and Virulence Factors

  • Dopamine dehydroxylase: E. lenta converts dopamine to m-tyramine through dehydroxylation, forming the second step of an interspecies relay where enterococcus faecalis first converts L-DOPA to dopamine via tyrosine decarboxylase (TyrDC). This two-step pathway significantly reduces levodopa bioavailability in Parkinson's disease patients (maini rekdal 2019 microbiome drug interactions parkinsons, in-vitro).
  • Cardiac glycoside reductase (Cgr): Inactivates digoxin in the gut lumen, reducing drug efficacy. This enzyme is strain-specific — only E. lenta strains carrying the Cgr operon metabolize digoxin (maddu 2025 microbiome drug interactions pharmacokinetic review, expert-opinion).
  • Beta-glucuronidase: Deconjugates glucuronidated estrogens, returning active estrogen to the circulation. This activity connects Eggerthella to the estrobolome and estrogen-dependent conditions.

Ecological Role

In the healthy gut, E. lenta occupies a low-abundance niche as part of the Actinobacteria minority. It becomes ecologically significant under two conditions:

  1. Competitor depletion: When metal-sensitive Clostridia (clusters IV and XIVa) are depleted by heavy metal exposure or other stressors, Eggerthella fills the vacated anaerobic niches. This is the pattern observed in MS, where E. lenta increases alongside Streptococcus as Clostridia decline (miyake 2015 dysbiosis ms clostridia depletion, cross-sectional).
  1. Uremic environment: In chronic kidney disease, the accumulation of urea and protein fermentation substrates favors proteolytic bacteria. E. lenta is consistently enriched in CKD patients and contributes to the production of uremic toxins including indoxyl sulfate and p-cresyl sulfate (wehedy 2022 human microbiome ckd double edged sword, expert-opinion).

The genus also participates in urolithin production from dietary polyphenols via the closely related family Eggerthellaceae. Urolithin A has anti-inflammatory and neuroprotective effects, providing a rare example where this group contributes beneficial metabolites (duarte silva 2022 microbial metabolites ms, expert-opinion).

Conditions Associated

Enriched in:

Key Studies

StudyFindingEvidence Level
maini rekdal 2019 microbiome drug interactions parkinsonsE. lenta dehydroxylates dopamine to m-tyramine; interspecies L-DOPA degradation pathway with E. faecalisIn vitro
miyake 2015 dysbiosis ms clostridia depletionEnriched in MS when Clostridia depleted; metal-tolerant opportunist patternCross-sectional
jiang 2021 hrt gut microbiome premature ovarian insufficiencyIncreased in POI; reversed by HRT; causes ovarian fibrosis in miceAnimal model
wehedy 2022 human microbiome ckd double edged swordEnriched in CKD; uremic toxin producerExpert opinion
maddu 2025 microbiome drug interactions pharmacokinetic reviewDigoxin inactivation via Cgr reductaseExpert opinion

Cross-References